Search ACNT
ASCENT INDUSTRIES CO.
Nasdaq · CIK 95953
Last close13.77
Daily change-0.18 (-1.29%)
10 Years gain+58.10%
Dividends TTM0
Dividend yield0.00%
Fundamental Analysis
ACNT · STANDARD
SIC 2800 · Chemicals & Allied Products · Fiscal year end 1231
Fundamental
52.7Momentum
73.4Acceleration
64.1Confidence
89.0Annual Revenue17
Quarterly Revenue74
Annual CFO17
Balance SheetAvailable
RankingEligible
Score Breakdown
Growth6.4 / 25
Quality19.0 / 25
Capital Efficiency0.0 / 20
Balance Sheet15.0 / 15
Shareholder Economics9.6 / 10
Forward Indicators0.0 / 5
Signals
Gross margin expansionGross margin improved by 6.6661 percentage points.
Operating leverageOperating margin improved by 4.677 percentage points.
ROIC expansionROIC improved by 0.0146 percentage points.
Net debt reductionNet debt declined versus the comparison period.
Share count reductionDiluted share count declined 9.5474%.
Key Metrics
Revenue Growth TTM18.1%OK
Revenue CAGR 3Y-34.11%OK
Gross Margin22.85%OK
Operating Margin-7.35%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC-7.55%OK
Incremental Operating Margin 3Yn/aNOT_MEANINGFUL
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y-9.55%OK
SBC / Revenuen/aMISSING
SBC / FCFn/aNOT_MEANINGFUL
Financial History
| Period | Revenue | Gross Profit | Operating Income | CFO | FCF | Gross Margin | Op Margin | FCF Margin | ROIC | Shares |
|---|---|---|---|---|---|---|---|---|---|---|
| 2025 FY Dec 31, 2025 | $74.94M | $17.21M | -$7.03M | -$519,000.00 | -$2.06M | 22.97% | -9.38% | -2.75% | -10.39% | 9.64M |
| 2025 FY Dec 31, 2024 | $80.76M | $10.69M | -$10.80M | $14.68M | $13.56M | 13.24% | -13.37% | 16.79% | -9.33% | 10.11M |
| 2024 FY Dec 31, 2023 | $193.18M | $1.53M | -$37.43M | $23.08M | $20.19M | 0.79% | -19.38% | 10.45% | -19.08% | 10.14M |
| 2023 FY Dec 31, 2022 | $261.99M | $43.29M | $14.54M | $5.58M | $2.18M | 16.52% | 5.55% | 0.83% | 4.92% | 10.41M |
| 2022 FY Dec 31, 2021 | $334.72M | $60.77M | $27.35M | $19.06M | $17.56M | 18.15% | 8.17% | 5.25% | 13.51% | 9.46M |
Formula Trace
| Metric | Value | Formula | Status | Source |
|---|---|---|---|---|
| Revenue TTM | $83.43M | sum latest 4 fiscal quarters Revenue | OK | 0000095953-26-000109, 0000095953-25-000124 |
| Revenue Growth TTM | 18.1% | Revenue_TTM / Revenue_TTM_1Y_ago - 1 | OK | 0000095953-26-000109, 0000095953-25-000124 |
| Revenue CAGR 3Y | -34.11% | (Revenue_current / Revenue_3Y_ago)^(1/3) - 1 | OK | 0000095953-26-000040 |
| Revenue CAGR 5Y | -21.78% | (Revenue_current / Revenue_5Y_ago)^(1/5) - 1 | OK | 0000095953-26-000040 |
| Gross Profit CAGR 3Y | -26.47% | (GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1 | OK | 0000095953-26-000040 |
| Operating Income Growth | n/a | OperatingIncome_current / OperatingIncome_prior_year - 1 | INSUFFICIENT_HISTORY | 0000095953-26-000109, 0000095953-25-000124 |
| FCF Growth | n/a | FCF_current / FCF_prior_year - 1 | INSUFFICIENT_HISTORY | derived |
| Revenue Growth Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Profit Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Operating Income Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| FCF Acceleration | n/a | 0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3) | INSUFFICIENT_HISTORY | derived |
| Gross Margin | 22.85% | Gross Profit / Revenue | OK | 0000095953-26-000109, 0000095953-25-000124 |
| Operating Margin | -7.35% | Operating Income / Revenue | OK | 0000095953-26-000109, 0000095953-25-000124 |
| ROIC | -7.55% | NOPAT / Average Invested Capital | OK | 0000095953-26-000109, 0000095953-25-000124 |
| Net Debt / CFO | n/a | Net Debt / CFO | NOT_MEANINGFUL | 0000095953-26-000109 |
| Current Ratio | 4.33x | Current Assets / Current Liabilities | OK | derived |
| Revenue per Diluted Share | $9.15 | Revenue / Diluted Shares | OK | 0000095953-26-000109, 0000095953-25-000124 |
| SBC / FCF | n/a | SBC / FCF | NOT_MEANINGFUL | derived |